Insmed revenue and financials
$105.23Change from previous close: +1.35%Absolute change: +$1.40
In the fiscal year ended December 2025, Insmed reported revenue of $606.42M (+66.73% year over year). The net loss was $1.28B.
Fiscal year ending in December. Sources and method on the page Methodology and sources.
At a glance
- Revenue growth
- +66.73%
- 2025 vs 2024
- Net margin
- -210.5%
- 2024: -251.2%
Financial data
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -88.8 | -223 | -248 | -220 | -206 | -262 | -196 | -181 | -123 | -184 | -131 | -136 |
| Depreciation and amortization | 4.7 | 4.5 | 5.0 | 3.5 | 3.2 | 2.6 | 2.2 | 2.2 | 2.2 | 2.3 | 2.2 | 2.2 |
| Capital expenditure | -6.3 | -3.5 | -16.6 | -2.4 | -3.5 | -10.1 | -6.8 | -3.7 | -6.8 | -4.7 | -2.2 | -2.9 |
| Investing cash flow | 24.5 | 266 | 389 | -762 | 228 | 80.4 | 132 | -1,003 | -6.8 | 295 | 1.8 | 7.1 |
| Financing cash flow | 27.2 | 29.5 | 33.9 | 33.4 | 858 | 29.0 | 159 | 397 | 781 | 3.0 | 123 | 1.2 |
| Debt issued | — | — | — | — | — | — | 150 | — | — | — | — | — |
| Debt repaid | -0.8 | -0.8 | -0.8 | -0.7 | -2.7 | -0.7 | -0.7 | -0.7 | -0.6 | -0.6 | 1.2 | -1.1 |
| Effect of exchange rates | -0.3 | -0.6 | 0.0 | -1.0 | 1.0 | 0.9 | -1.5 | 1.8 | -0.7 | -1.0 | 1.0 | 2.2 |
| Net change in cash | -37.4 | 71.7 | 176 | -950 | 881 | -152 | 93.6 | -785 | 651 | 113 | -4.7 | -126 |
| Free cash flow | -95.1 | -226 | -264 | -222 | -209 | -272 | -203 | -185 | -130 | -189 | -133 | -139 |
| Levered free cash flow | -41.2 | -232 | -235 | -63.2 | -75.6 | -190 | -111 | -166 | -14.0 | -128 | -71.2 | -93.6 |